(2S,4R)-Benzyl 4-hydroxypyrrolidine-2-carboxylatehydrochloride, 95.0%, 25g

(4,4'-Di-tert-butyl-2,2'-bipyridine-kappa~2~N~1~,N~1'~)[bis[3,5-difluoro-2-(5-methyl-2-pyridinyl-kappaN)phenyl-kappaC~1~]]iridium Hexafluorophosphate>90.0%(HPLC)200mg

6-Bromobenzo[d]oxazole, 95.0%, 250mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-thiopyran 1,1-dioxide, 98+%, 500mg

(S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-OL, 95.0%, 250mg

Ethyl 3-amino-5-chloropyrazine-2-carboxylate, 95.0%, 250mg

6-amino-4-methyl-2H-1,4-benzoxazin-3(4H)-one, 95.0%, 1g

2-Bromo-3-methylbenzaldehyde, 95.0%, 100g

2-Vinyl-2,3-dihydrobenzo[d][1,3,2]diazaborinin-4(1H)-one, 1g

tert-butyl 3-[3-(methoxycarbonyl)phenyl]piperidine-1-carboxylate, 97.0%, 1g

Soluzione standard ICP di uranio, ROTI®Star, 250 ml, HDPE

(S)-2-Iodomethyl-pyrrolidine-1-carboxylic acid tert-butyl ester, 100mg

2-Fluoro-6-hydrazinylpyridine, 95+%, 250mg